Tech Company Financing Transactions

NeuroPace Funding Round

NeuroPace, based in Mountain View, secured $74 million from KCK Group, OrbiMed and private investors.

Transaction Overview

Company Name
Announced On
10/25/2017
Transaction Type
Venture Equity
Amount
$74,000,000
Round
Undisclosed
Investors

KCK Group (Lead Investor)

OrbiMed (Lead Investor)

Proceeds Purpose
The medical device maker looks to rapidly expand commercialization of its device to treat epileptic seizures.

Company Information

Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
455 N. Bernardo Ave.
Mountain View, CA 94043
USA
Email Address
Overview
NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders by responsive brain stimulation. The company's initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.
Profile
NeuroPace LinkedIn Company Profile
Social Media
NeuroPace Company Twitter Account
Company News
NeuroPace News
Facebook
NeuroPace on Facebook
YouTube
NeuroPace on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Michael Favet
  Michael Favet LinkedIn Profile  Michael Favet Twitter Account  Michael Favet News  Michael Favet on Facebook
Chief Financial Officer
Rebecca Kuhn
  Rebecca Kuhn LinkedIn Profile  Rebecca Kuhn Twitter Account  Rebecca Kuhn News  Rebecca Kuhn on Facebook
Chief Medical Officer
Martha Morrell
  Martha Morrell LinkedIn Profile  Martha Morrell Twitter Account  Martha Morrell News  Martha Morrell on Facebook
VP - General Counsel
Pamela Maher
  Pamela Maher LinkedIn Profile  Pamela Maher Twitter Account  Pamela Maher News  Pamela Maher on Facebook
VP - Human Resources
Irene Thomas
  Irene Thomas LinkedIn Profile  Irene Thomas Twitter Account  Irene Thomas News  Irene Thomas on Facebook
VP - Marketing
Chi Nguyen
  Chi Nguyen LinkedIn Profile  Chi Nguyen Twitter Account  Chi Nguyen News  Chi Nguyen on Facebook
VP - Regulatory Affairs
Isabella Abati
  Isabella Abati LinkedIn Profile  Isabella Abati Twitter Account  Isabella Abati News  Isabella Abati on Facebook
VP - Sales
Mark Saxton
  Mark Saxton LinkedIn Profile  Mark Saxton Twitter Account  Mark Saxton News  Mark Saxton on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/25/2017: YmAbs Therapeutics venture capital transaction
Next: 10/25/2017: Shift Technology venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on all VC transactions involving tech companies. All VC database entries on this site are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary